Recent Finacing
Recent Raise
Alacrity Biosciences develops therapeutics for ocular diseases—dry eye, glaucoma, and retinal disorders, with lead compound ALTY-501 completing a mid-stage human trial; headquartered in Laguna Hills, California.
Focus Areas
Total Raised
Funding round